Page "Experimental cancer treatment" Paragraph 13

The first clinical trial, involving 30 women with breast cancer, combined insulin with low-dose methotrexate ( a common chemotherapy drug ) resulted in greatly increased stable disease, and much reduced progressive disease, compared with insulin or low-dose methotrexate alone.